Khemla, S., Meesing, A., Sribenjalux, W. and Chetchotisakd, P. 2023. Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. Drug Target Insights. 17, 1 (Apr. 2023), 45–53. DOI:https://doi.org/10.33393/dti.2023.2529.